Skip to main content
GutCited

Omega-3 Fatty Acids (EPA/DHA) के लिए Ulcerative Colitis (UC)

C

Mixed results in maintaining UC remission. Some meta-analyses show modest benefit; others show no significant effect. EPA may be more beneficial than DHA.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Domega\u002D3\u002Dfatty\u002Dacids\u0026condition\u003Dibd\u002Dulcerative\u002Dcolitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

निष्कर्ष

Mixed results in maintaining UC remission. Some meta-analyses show modest benefit; others show no significant effect. EPA may be more beneficial than DHA.

Key Study Findings

Review
Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: patients with ulcerative colitis

Review
Are there Effective Vegan-Friendly Supplements for Optimizing Health and Sports Performance? a Narrative Review.
Dose: None बनाम: None Outcome: Athletic performance and nutritional optimization प्रभाव: None None

जनसंख्या: Vegan athletes (narrative review)

Review
From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel …
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Review
Gut microbiome-centric nutritional strategies in inflammatory bowel disease: Modulating dysbiosis for therapeutic benefit.
Dose: None बनाम: None Outcome: IBD microbiota modulation and immune regulation प्रभाव: None None

जनसंख्या: IBD patients (review of nutritional interventions)

Review
Association between Omega-3 fatty acids and autoimmune disease: Evidence from the umbrella review and Mendelian …
Dose: None बनाम: None Outcome: Colitis severity प्रभाव: None None

जनसंख्या: Crohn's disease patients

Other
Interaction between diet and genetics in patients with inflammatory bowel disease.
Dose: None बनाम: None Outcome: Diet-genetics interaction in IBD प्रभाव: None None

जनसंख्या: IBD patients (editorial commentary)

Key Statistics

8

अध्ययन

1000

प्रतिभागी

Mixed

C

ग्रेड

Referenced Papers

Nutrients 2022 61 उद्धरण
Foods (Basel, Switzerland) 2021 96 उद्धरण
Nutrients 2021 27 उद्धरण
Therapeutic advances in … 2020 21 उद्धरण
Gastroenterology clinics of … 2018 67 उद्धरण
Medical principles and … 2017 45 उद्धरण
Annals of gastroenterology 2016 80 उद्धरण
European journal of … 2016 79 उद्धरण
Clinics in dermatology 2016 19 उद्धरण
World journal of … 2014 36 उद्धरण
World journal of … 2014 25 उद्धरण
Alimentary pharmacology & … 2013 128 उद्धरण
World journal of … 2013 56 उद्धरण
The British journal … 2012 145 उद्धरण
The Cochrane database … 2012 130 उद्धरण
The American journal … 2011 946 उद्धरण
JRSM short reports 2010 11 उद्धरण
The Cochrane database … 2007 118 उद्धरण
Journal of the … 2002 2016 उद्धरण
Nutrition (Burbank, Los … 2000 64 उद्धरण
Drugs 1998 99 उद्धरण
The American journal … 1998 84 उद्धरण
Bailliere's clinical gastroenterology 1997 26 उद्धरण
The American journal … 1991 2278 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
1,000-2,000 mg combined EPA/DHA per day
ibdsupport:
2,000-4,000 mg/day combined EPA/DHA (higher EPA ratio may be more beneficial)

अधिकतम सीमा: 3,000 mg/day combined EPA/DHA (FDA GRAS limit)

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Neutral --
None -- Neutral --
95% -- Mixed 124
95% -- Mixed --

सेवन का सर्वोत्तम समय: With meals containing fat for better absorption

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Fishy aftertaste and burping
  • Mild gastrointestinal discomfort (nausea, diarrhea)
  • Potential increased bleeding time at very high doses (>3 g/day)
  • May lower blood pressure slightly

ज्ञात अंतःक्रियाएँ

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)
  • Cyclosporine (fish oil may reduce cyclosporine nephrotoxicity but monitor levels)

सहनीय अधिकतम सेवन: 3,000 mg/day combined EPA/DHA (FDA GRAS limit)

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Omega-3 Fatty Acids (EPA/DHA) help with Ulcerative Colitis (UC)?
Based on 8 studies with 1,000 participants, there is limited but promising evidence that Omega-3 Fatty Acids (EPA/DHA) may support Ulcerative Colitis (UC) management. Our evidence grade is C (Some Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Ulcerative Colitis (UC)?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined EPA/DHA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Mild gastrointestinal discomfort (nausea, diarrhea), Potential increased bleeding time at very high doses (>3 g/day), May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Ulcerative Colitis (UC)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 1,000 total participants. The overall direction of effect is mixed.

Related Evidence

इसके लिए अन्य सामग्री Ulcerative Colitis (UC)

Omega-3 Fatty Acids (EPA/DHA) अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।